The impact of COVID-19 on health care-associated infections in intensive care units in low- and middle-income countries: International Nosocomial Infection Control Consortium (INICC) findings.
COVID-19
Coronavirus
Developing countries
Health care–associated infection
Hospital infection
INICC
Infection control
Infection prevention
International
Low- and middle-income countries
Nosocomial infection
Surveillance
nosocomial infection control consortium
Journal
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
07
01
2022
revised:
16
02
2022
accepted:
18
02
2022
pubmed:
27
2
2022
medline:
29
4
2022
entrez:
26
2
2022
Statut:
ppublish
Résumé
This study examines the impact of the COVID-19 pandemic on health care-associated infection (HAI) incidence in low- and middle-income countries (LMICs). Patients from 7 LMICs were followed up during hospital intensive care unit (ICU) stays from January 2019 to May 2020. HAI rates were calculated using the International Nosocomial Infection Control Consortium (INICC) Surveillance Online System applying the Centers for Disease Control and Prevention's National Healthcare Safety Network (CDC-NHSN) criteria. Pre-COVID-19 rates for 2019 were compared with COVID-19 era rates for 2020 for central line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), ventilator-associated events (VAEs), mortality, and length of stay (LOS). A total of 7,775 patients were followed up for 49,506 bed days. The 2019 to 2020 rate comparisons were 2.54 and 4.73 CLABSIs per 1,000 central line days (risk ratio [RR] = 1.85, p = .0006), 9.71 and 12.58 VAEs per 1,000 mechanical ventilator days (RR = 1.29, p = .10), and 1.64 and 1.43 CAUTIs per 1,000 urinary catheter days (RR = 1.14; p = .69). Mortality rates were 15.2% and 23.2% for 2019 and 2020 (RR = 1.42; p < .0001), respectively. Mean LOS for 2019 and 2020 were 6.02 and 7.54 days (RR = 1.21, p < .0001), respectively. This study documents an increase in HAI rates in 7 LMICs during the first 5 months of the COVID-19 pandemic and highlights the need to reprioritize and return to conventional infection prevention practices.
Sections du résumé
BACKGROUND
BACKGROUND
This study examines the impact of the COVID-19 pandemic on health care-associated infection (HAI) incidence in low- and middle-income countries (LMICs).
METHODS
METHODS
Patients from 7 LMICs were followed up during hospital intensive care unit (ICU) stays from January 2019 to May 2020. HAI rates were calculated using the International Nosocomial Infection Control Consortium (INICC) Surveillance Online System applying the Centers for Disease Control and Prevention's National Healthcare Safety Network (CDC-NHSN) criteria. Pre-COVID-19 rates for 2019 were compared with COVID-19 era rates for 2020 for central line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), ventilator-associated events (VAEs), mortality, and length of stay (LOS).
RESULTS
RESULTS
A total of 7,775 patients were followed up for 49,506 bed days. The 2019 to 2020 rate comparisons were 2.54 and 4.73 CLABSIs per 1,000 central line days (risk ratio [RR] = 1.85, p = .0006), 9.71 and 12.58 VAEs per 1,000 mechanical ventilator days (RR = 1.29, p = .10), and 1.64 and 1.43 CAUTIs per 1,000 urinary catheter days (RR = 1.14; p = .69). Mortality rates were 15.2% and 23.2% for 2019 and 2020 (RR = 1.42; p < .0001), respectively. Mean LOS for 2019 and 2020 were 6.02 and 7.54 days (RR = 1.21, p < .0001), respectively.
DISCUSSION
CONCLUSIONS
This study documents an increase in HAI rates in 7 LMICs during the first 5 months of the COVID-19 pandemic and highlights the need to reprioritize and return to conventional infection prevention practices.
Identifiants
pubmed: 35218928
pii: S1201-9712(22)00120-5
doi: 10.1016/j.ijid.2022.02.041
pmc: PMC8866162
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
83-88Informations de copyright
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Références
Am J Infect Control. 2016 Jun 1;44(6):e81-90
pubmed: 26975716
Infect Control Hosp Epidemiol. 2022 Jan;43(1):26-31
pubmed: 33602361
Infect Control Hosp Epidemiol. 2012 Jul;33(7):704-10
pubmed: 22669232
Infect Control Hosp Epidemiol. 2022 Jan;43(1):32-39
pubmed: 33602380
Infect Control Hosp Epidemiol. 2021 Aug;42(8):997-1000
pubmed: 33213553
Infection. 2012 Aug;40(4):415-23
pubmed: 22371234
Infection. 2012 Oct;40(5):517-26
pubmed: 22711598
Crit Care. 2021 Jan 11;25(1):25
pubmed: 33430915
Am J Infect Control. 2008 Jun;36(5):309-32
pubmed: 18538699
Am J Infect Control. 2021 Jun;49(6):657-662
pubmed: 33775741
Am J Infect Control. 2020 Nov;48(11):1409-1411
pubmed: 32621857
Infect Control Hosp Epidemiol. 2013 Apr;34(4):415-23
pubmed: 23466916
Infect Control Hosp Epidemiol. 2010 Dec;31(12):1264-72
pubmed: 21029008
Infect Control Hosp Epidemiol. 2021 Jun 03;:1-5
pubmed: 34078507
Crit Care Med. 2012 Dec;40(12):3121-8
pubmed: 22975890
Infect Control Hosp Epidemiol. 2013 Jun;34(6):597-604
pubmed: 23651890
Am J Infect Control. 2021 Oct;49(10):1267-1274
pubmed: 33901588
Infect Control Hosp Epidemiol. 2013 Mar;34(3):229-37
pubmed: 23388356
Clin Microbiol Infect. 2021 Mar;27(3):451-457
pubmed: 33223114
Infect Control Hosp Epidemiol. 2012 Jul;33(7):696-703
pubmed: 22669231
Am J Infect Control. 1991 Feb;19(1):19-35
pubmed: 1850582
Infect Control Hosp Epidemiol. 2022 Jan;43(1):12-25
pubmed: 34473013
Am J Infect Control. 2008 Nov;36(9):e1-12
pubmed: 18992646
Infect Control Hosp Epidemiol. 2022 Jun;43(6):790-793
pubmed: 33719981